The landscape of the Moroccan insurance sector is bracing for a significant shift as Sanlam Maroc moves toward the full absorption of Allianz Maroc. Scheduled for completion by early July 2026, the merger is set to create the third-largest insurance entity in the Kingdom, claiming a combined market share of 13.4%.
This consolidation is not an isolated event but the culmination of a broader strategic alliance. In late 2021, Sanlam and Allianz announced a joint venture to integrate their operations across Africa, excluding South Africa. This pan-African initiative, now operating as SanlamAllianz across 25 countries, has finally reached its operational phase in Morocco after navigating a strict “hold separate” regulatory period to ensure fair competition.
For the Moroccan market, the merger represents more than just a growth in size. It is a calculated industrial and financial maneuver designed to balance portfolios, optimize technical ratios, and expand a distribution network that, before competitive adjustments, will exceed 740 points of contact.
A Strategic Rebalancing of the Moroccan Market
The logic behind the Sanlam-Allianz merger Morocco is rooted in complementarity. Sanlam Maroc enters the deal with a dominant footprint in “Non-Life” insurance—specifically mass-market segments like automobile, health, and fire insurance. However, the company has recently faced headwinds in its “Life” insurance segment.
Data from the first half of 2025 reveals a stark contrast in trajectory: Sanlam Maroc saw a 38.1% decline in Life insurance activity, largely attributed to the termination of its bancassurance partnership with Crédit du Maroc. In contrast, Allianz Maroc reported a robust 66.8% surge in the same segment during the same period, bringing in 296.6 million MAD.
By absorbing Allianz, Sanlam effectively plugs this gap, gaining immediate momentum in Life insurance and expanding its reach into corporate clients and Small and Medium Enterprises (SMEs). This allows the new entity to diversify its risk profile while maintaining its stronghold on the retail consumer market.
| Segment | Sanlam Maroc Strength | Allianz Maroc Contribution |
|---|---|---|
| Non-Life | Mass market, Auto, Health | Corporate, SME, Technical branches |
| Life | Broad base (currently contracting) | High growth, strong dynamics |
| Distribution | 500+ General Agents | 240+ Agents and direct offices |
Technical Recovery and Operational Scale
While the merger increases scale, the focus is equally on technical efficiency. Allianz Maroc had a challenging 2024, marked by a net loss of 108.5 million MAD and a combined ratio of 124%, driven primarily by a spike in claims. However, 2025 data suggests a normalization of the portfolio, with the company returning to profitability and recording a net result of 262 million MAD.
Financial analysts expect the combined entity to see a progressive improvement in technical ratios. The Non-Life S/P (Loss) ratio is projected to drop from 76.7% in 2025 to 74.5% in 2026, eventually reaching 73.5% by 2030. This improvement is expected to stem from the mutualization of risk and a more balanced activity mix.
The shift is also expected to impact the operating coefficient. In the Life segment, the coefficient is forecasted to slide from 16.4% in 2025 to 13.3% by 2030. In Non-Life, a similar trajectory is expected, moving from 27.4% in 2025 toward 25% by 2030. This suggests that the merger is less about aggressive cost-cutting and more about the “industrialization” of the portfolio—diluting fixed costs across a larger, more productive network.
Decoding the Stock Market Potential
For investors tracking the Casablanca Stock Exchange, the merger necessitates a complete recalibration of how Sanlam Maroc’s shares are valued. Because the operation involves an increase in capital to accommodate Allianz Maroc shareholders, the current “facial” share price no longer provides an accurate picture of the stock’s potential.
The merger is based on a parity of two Allianz Maroc shares for every five Sanlam Maroc shares, resulting in the creation of 1.225 million new shares. This brings the total post-fusion share count to 5,341,874.
According to analysis from BKGR, the theoretical post-fusion price is set at 2,145 DH. Using this as the baseline—rather than the current market price—analysts have set a target price of 3,011 DH. This represents a potential upside of approximately 40%, supporting a “Buy” recommendation for the title.
This valuation is underpinned by an expected surge in profitability. Net results are projected to climb to 856 million MAD in 2026 and 971 million MAD in 2027, up from 452 million MAD in 2025. While the Price-to-Earnings (PER) ratio remains demanding at 19.5x for 2026, it is expected to moderate to 17.2x by 2027 as earnings grow.
Disclaimer: This article is for informational purposes only and does not constitute financial or investment advice.
The next critical milestone for the integration will be the finalization of structural commitments with the Moroccan Competition Council, which will clear the path for the official merger in July 2026.
What are your thoughts on the consolidation of the African insurance market? Share your views in the comments or share this analysis with your network.
